To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Serum erythropoietin and … - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Serum erythropoietin and outcome after ischaemic stroke: a prospective study.

Journal article
Authors N David Åberg
Tara M Stanne
Katarina Jood
Linus Schiöler
Christian Blomstrand
Ulf Andreasson
Kaj Blennow
Henrik Zetterberg
Jörgen Isgaard
Christina Jern
Johan Svensson
Published in BMJ open
Volume 6
Issue 2
Pages e009827
ISSN 2044-6055
Publication year 2016
Published at Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Institute of Medicine, Department of Public Health and Community Medicine, Section of Occupational and environmental medicine
Institute of Medicine, Department of Internal Medicine and Clinical Nutrition
Pages e009827
Language en
Subject categories Neurochemistry


Erythropoietin (EPO), which is inversely associated with blood haemoglobin (Hb), exerts neuroprotective effects in experimental ischaemic stroke (IS). However, clinical treatment trials have so far been negative. Here, in patients with IS, we analysed whether serum EPO is associated with (1) initial stroke severity, (2) recovery and (3) functional outcome.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?